GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Visioneering Technologies Inc (ASX:VTI) » Definitions » Capex-to-Revenue

Visioneering Technologies (ASX:VTI) Capex-to-Revenue : 0.00 (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Visioneering Technologies Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Visioneering Technologies's Capital Expenditure for the six months ended in Dec. 2023 was A$0.00 Mil. Its Revenue for the six months ended in Dec. 2023 was A$5.98 Mil.

Hence, Visioneering Technologies's Capex-to-Revenue for the six months ended in Dec. 2023 was 0.00.


Visioneering Technologies Capex-to-Revenue Historical Data

The historical data trend for Visioneering Technologies's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Visioneering Technologies Capex-to-Revenue Chart

Visioneering Technologies Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
Get a 7-Day Free Trial - 0.01 - - -

Visioneering Technologies Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Visioneering Technologies's Capex-to-Revenue

For the Medical Devices subindustry, Visioneering Technologies's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Visioneering Technologies's Capex-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Visioneering Technologies's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Visioneering Technologies's Capex-to-Revenue falls into.



Visioneering Technologies Capex-to-Revenue Calculation

Visioneering Technologies's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 12.953
=0.00

Visioneering Technologies's Capex-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 5.975
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Visioneering Technologies  (ASX:VTI) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Visioneering Technologies Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Visioneering Technologies's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Visioneering Technologies (ASX:VTI) Business Description

Traded in Other Exchanges
N/A
Address
10745 Westside Way, Suite 200, Alpharetta, GA, USA, 30009
Visioneering Technologies Inc is a medical device company. It designs, manufactures, sales and distributes its NaturalVue daily disposable multifocal contact lenses for adults with Presbyopia and children with Myopia. The company offers NaturalVue MF contact lenses. Its Multifocal contact lens provides Presbyopia patients with near, intermediate, and distance vision and which is much easier for eye care professionals to fit their patients.

Visioneering Technologies (ASX:VTI) Headlines

From GuruFocus

Top 5 4th Quarter Trades of H&H Retirement Design & Management INC

By GuruFocus Research GuruFocus Editor 01-17-2023

Top 5 3rd Quarter Trades of Patriot Investment Management Inc.

By GuruFocus Research GuruFocus Editor 11-03-2022

AGILIS PARTNERS LLC Buys 1, Sells 4 in 4th Quarter

By GuruFocus Research GuruFocus Editor 02-07-2023

Northstar Group, Inc. Buys 2, Sells 3 in 4th Quarter

By GuruFocus Research GuruFocus Editor 01-26-2023

Top 5 4th Quarter Trades of Peterson Wealth Advisors, LLC

By GuruFocus Research GuruFocus Editor 01-21-2023

CONTINENTAL INVESTORS SERVICES, INC.'s Top 5 Buys of the 3rd Quarter

By GuruFocus Research GuruFocus Editor 11-23-2022

Top 5 4th Quarter Trades of Novo Holdings A/S

By GuruFocus Research GuruFocus Editor 02-18-2023

Monashee Investment Management LLC Buys 4, Sells 1 in 3rd Quarter

By GuruFocus Research GuruFocus Editor 11-01-2022

Top 5 4th Quarter Trades of OPPENHEIMER ASSET MANAGEMENT INC.

By GuruFocus Research GuruFocus Editor 02-07-2023

Gleason Group, Inc. Goes on Buying Spree in 4th Quarter

By GuruFocus Research GuruFocus Editor 01-11-2023